Sitemap

Latest News

• General communications
  • Current information on therapeutic products safety
  • Archive
• Coronavirus disease (COVID-19) Pandemic
  • Reports of suspected side-effects of COVID-19 vaccines
  • FAQ on the COVID-19 vaccines
  • Current status of authorisations for combating COVID-19
  • Reports of suspected adverse reactions to COVID-19 vaccines
• Specials
  • Revision of the TPA
• New on this website
  • Specification documents
• Newsletter
• RSS Feeds

Human medicines

• Clinical trials
  • Submission of applications
  • Clinical trials on medicinal products
  • Temporary authorisation to use medicinal products in accordance with Article 9b para. 1 TPA
  • Fees
• Licensing
  • Authorisations
  • Special authorisation
  • Microbiological Laboratories
• Authorisations
  • Information
  • New authorisations
  • Real World Evidence (RWE)
  • SwissPAR
  • Public Summary SwissPAR
  • Human Medicines Expert Committee (HMEC)
  • Expert Commission for Radiopharmaceuticals (ECRP)
  • Roundtable Regulatory Affairs
  • Publication platform
• Special categories
  • Authorised narcotics
  • Blood and blood components
  • Medicines for children
  • Advanced Therapy Medicinal Products
  • Controlled substances according to Art. 21 TPA
• Combination products
  • Information
• Questions on delimitation
• Market surveillance
  • Pharmacovigilance
  • Topics
  • Risk Management (Signalmanagement, PSURs, RMPs/RMP summaries)
  • Healthcare Professional Communications
  • Haemovigilance
  • Quality defects and batch recalls
  • Out-of-Stock
  • Illegal drug imports
  • Advertising of medicinal products

Veterinary medicines

• Information
• Licensing
  • Authorisations
  • Special authorisation
• Authorisations
  • New authorisations
  • Veterinary Medicines Expert Committee (VMEC)
  • Roundtable VMP
• Special categories
  • Authorised narcotics
• Market surveillance
  • Healthcare Professional Communication
  • Report adverse drug reaction to a veterinary medicinal product
  • Batch recalls
  • Out-of-Stock
  • Meldung von Qualitätsmängeln
  • Import of veterinary medicines by veterinarians
  • Illegale Arzneimittelimporte
  • Arzneimittelwerbung
• International collaboration
  • Simultaneous Review
• Questions on delimitation

Complementary & herbal medicines

• Latest News
  • New authorisations CHM
  • Events on CHM subjects
  • Archive
• Herbal medicinal products
  • Simplified authorisation procedures
  • Notification procedure for teas
• Cough and throat lozenges and pastilles
• Homeopathic and anthroposophic medicinal products
  • Simplified authorisation with indication
  • Simplified authorisation without indication “reduced dossier”
  • Simplified authorisation without indication “complete dossier”
  • Authorisation without indication by means of notification (notification procedure)
• Asian medicinal products
  • Simplified authorisation with indication
  • Simplified authorisation without indication
  • Authorisation without indication by means of notification (notification procedure)
• Other alternative treatments
  • Medicinal products for gemmotherapy
  • Other complementary medicinal products
• Other authorisation procedures
• Frequently Asked Questions on CHMs – FAQ CHM
• CHM round table
• Questions and links

Medical devices

• List of FSCAs
• News
  • Events
  • Information on specific medical devices
  • Archive
• Regulation of medical devices
  • Frequently Asked Questions
  • Designated bodies
  • Standards and common specifications
  • Foreign inspections
  • Delegated Acts of the EU
  • Roundtable on Medical Technology (RTMT)
  • New medical devices regulations
  • Information from the European environment
  • International Medical Device Regulators Forum (IMDRF)
• swissdamed
  • Overview
  • Registering economic operators (CHRN)
  • Unique Device Identifiers (UDI)
• Clinical trials
  • Clinical investigations
  • Performance studies
  • Announcements
• Market access
  • Obligations for authorised representatives, importers and distributors
  • Registering economic operators (CHRN)
  • Swiss authorised representative (CH-REP)
  • Unique Device Identifiers (UDI)
  • Notification of medical devices
  • Notification of IVDs
  • Notification of devitalised human tissue
  • New transitional provisions
  • Exemption authorisations
  • Import, sale and distribution
• Reporting incidents & FSCAs (vigilance)
  • Users
  • Economic operators
• Market surveillance
  • Suspicion reports
  • Inspections of market participants
  • Announcements on market control issues
• Export certificates and other certificates
  • Export certificates (Free Sales Certificates)
  • Other certificates
  • Information to third countries
• Surveillance of healthcare institutions
  • Reprocessing
  • Maintenance
  • Vigilance
  • Procurement
• Contacts / Links
  • Questions frequently asked by patients

Services & lists

• Medicinal product information
• Documents and Forms
• Lists and directories
• eGov services
  • Swissmedic Portal
  • Swissmedic Portal
  • eSubmissions
  • Safety communication
  • eMessage
  • CPP
  • GMP/GDP
  • ElViS
  • B2B gateway
  • Licences - major changes
  • MESA
  • NDS-WEB
  • OCABR
• Submissions
  • Information
  • Support
  • Applications for clinical trials for medicinal products
  • Formal requirements
  • eCTD
  • eCTD v4.0
  • eDok
  • Paper
  • Archive access
  • Electronic signatures
• Questions on delimitation
• Events
  • Archive
  • Speaking engagement
• Laboratories (OMCL)
  • Approved batches
• Authorization Holder

About us

• Institute
  • Strategic objectives
  • Principles
  • Tasks
• Organization
  • Agency Council
  • Management Board
• National collaboration
  • Roundtable eCTD
  • Patient and consumer organisations
  • Roundtable Regulatory Affairs
  • Roundtable VMP
  • Roundtable CHM
  • Roundtable GMP/GDP
  • Roundtable on Medical Technology (RTMT)
  • Roundtable Innovation (RTI)
  • Expert Panel for Delimitation Questions
• International collaboration
  • Bilateral collaboration with partner authorities
  • Multilateral co-operation with international organisations / initiatives
• Regulatory Systems Strengthening
  • AMRH Programme
  • Scientific Advice and Authorisation for Global Health Products (MAGHP)
  • Training
• Publications
  • Swissmedic Journal
  • Swissmedic Visible
  • SwissPAR
  • Public Summary SwissPAR
  • Annual Report
  • Therapeutic Products Act
  • Swissmedic videos
• Jobs
  • Vacancies - SWE

Visible